CN101185672A - Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny - Google Patents

Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny Download PDF

Info

Publication number
CN101185672A
CN101185672A CNA2007101162003A CN200710116200A CN101185672A CN 101185672 A CN101185672 A CN 101185672A CN A2007101162003 A CNA2007101162003 A CN A2007101162003A CN 200710116200 A CN200710116200 A CN 200710116200A CN 101185672 A CN101185672 A CN 101185672A
Authority
CN
China
Prior art keywords
grams
chinese medicine
treating lumbar
traditional chinese
hyperosteogeny
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2007101162003A
Other languages
Chinese (zh)
Other versions
CN101185672B (en
Inventor
崔月清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2007101162003A priority Critical patent/CN101185672B/en
Publication of CN101185672A publication Critical patent/CN101185672A/en
Application granted granted Critical
Publication of CN101185672B publication Critical patent/CN101185672B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine decoction taken orally for treating lumbar hyperosteogeny, belonging to the field of traditional Chinese medicine, which is prepared by 10 grams of dipsacaceae, ,10 grams of pubescent angelica root, , 10 grams of achyranthes, 30 grams of ,rhizome drynariae, ,45 grams of suberect spatholobus stem, 12 grams of loranthus parasiticus, ,10 grams of peach kernel, ,and 15 grams of cortex periplocae,. The medicine is to be decocted by water and taken for one dose a day, two to three times for one dose, and thirty days for a course of treatment. The invention has the advantages that after the combination of the medicines, the drug effect possesses synergistic action; the medicine used for treating lumbar hyperosteogeny can expel wind and remove damness, activate blood and relieve pain; the healing effect in the process of treating lumbar hyperosteogeny is remarkable; verified by 90 cases of clinical validation, the invention has the effective rate of 96 percent.

Description

A kind of Chinese medicine decoction that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration
Technical field
The present invention relates to a kind of Chinese medicine preparation, be specially a kind of Chinese medicine decoction that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration.
Background technology
The ligament that plays elastic reaction on the vertebrae after people in middle age begins to relax, and the cartilage and the intervertebral disc that play cushioning effect begin to degenerate, and the regulative mechanism of human motion itself, compensatory ground grow biological this of some chelas and be called hyperosteogeny at the vertebra edge.
The method of state's internal therapy bone matrix hyperplasia has following several at present: the unidirectional current drug iontophoresis, but be liquid because of importing medicine, volatile, drug effect is not lasting, has limited the therapeutic effect of this method; Massage and traction are only treated the part and have but been ignored integrally regulating in the human body, therefore, can only play temporary transient analgesic effect, and can not reach the purpose of treatment; Western medicine, at present doctor trained in Western medicine does not still have effective medicine to this disease, takes stopgap measures and does not effect a permanent cure, and the state of an illness easily recurs.
Summary of the invention
The present invention develops a kind of medicine for the treatment of lumbar vertebra hyperosteogeny on the basis of the mechanism of the morbidity of further investigation lumbar vertebra hyperosteogeny, can more effective treatment lumbar vertebra hyperosteogeny.
The technical scheme that technical solution problem of the present invention is taked is:
This kind Chinese medicine decoction that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration is characterized in that the crude drug of making effective ingredient by following weight is: Radix Dipsaci 10 grams, Radix Angelicae Pubescentis 10 grams, Radix Achyranthis Bidentatae 10 grams, Rhizoma Drynariae 30 grams, Caulis Spatholobi 45 grams, Herba Taxilli 12 grams, Semen Persicae 10 grams, Cortex Acanthopancis 15 grams.
Preparation and instructions of taking:
Be decocted in water for oral dose, every day, potion was obeyed 2~3 times for every dose, and 30 days is a course of treatment.
Pharmacological action:
Radix Dipsaci: invigorating the liver and kidney, reuniting the fractured tendons and bones, blood circulation regulating.Control aching pain in waist and back, the foot and knee being feeble, vaginal bleeding during pregnancy, metrorrhagia, leukorrhagia, seminal emission, traumatic injury, anal fistula, the carbuncle skin ulcer is swollen.
Radix Angelicae Pubescentis: dispel the wind, win and wet, cold expelling, pain relieving.Control anemofrigid-damp arthralgia, soreness of waist and knee joint, trick spasm and pain, chronic tracheitis, headache, toothache.
Radix Achyranthis Bidentatae: dissipating blood stasis blood, subduing inflammation.Control gonorrhea, hematuria, amenorrhea , mass in the abdomen, difficult labour, retention of placenta, postnatal blood stasis stomachache, sore throat, carbuncle, traumatic injury.
Rhizoma Drynariae: the kidney invigorating, invigorate blood circulation hemostasis.Control suffer from a deficiency of the kidney chronic diarrhea and lumbago, rheumatic arthralgia, toothache, tinnitus, traumatic injury sprain and contusion, bone injury, appendicitis, alopecia areata, clavus.
Caulis Spatholobi: blood circulation promoting and blood stasis dispelling, have enrich blood, invigorate blood circulation, the effect of collateral dredging.Control soreness of waist and knee joint, paralysis and numbness, menoxenia.
Herba Taxilli: invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, the meridian dredging, beneficial blood, antiabortive.Control soreness of waist and knee joint, hemiplegia a little less than the muscles and bones flaccidity, beriberi, anemofrigid-damp arthralgia, vaginal bleeding during pregnancy metrorrhagia, lack of lactation after delivery.
Semen Persicae: blood stasis removing and clots absorbing, moisturize laxation.Control amenorrhea , mass in the abdomen, calentura blood-retention, migratory arthralgia, malaria, traumatic injury, swelling and pain due to blood stasis, the dry constipation of blood.
Cortex Acanthopancis: wind-damp dispelling, strengthening bone and muscle, blood circulation and promoting silt.Control anemofrigid-damp arthralgia, the muscles and bones contraction is anxious, lumbago, sexual impotence, skin ulcer cellulitis toxic swelling, traumatic injury impairment caused by overstrain.
The present invention with above drug regimen after, drug effect has synergism.The medicine of this kind treatment lumbar vertebra hyperosteogeny can dispeiling pathogenic wind and removing dampness, and promoting blood circulation and stopping pain is evident in efficacy in the process of treatment lumbar vertebra hyperosteogeny, through clinical 90 example checkings, effective percentage 96%.
Model case
Example 1: Yu Pengyun, 42 years old, people from Hubei Province, skelalgia unbearably, femur, thigh pain, numbness can't normally be walked, be stood.Local hospital diagnosis: lumbar vertebra hyperosteogeny bony spur, through taking Drug therapy of the present invention after two courses of treatment, the sensation skelalgia is sent out a cool situation and is clearly better, and just runs into overcast and rainy lower limb and still numbness can occur, chilly sensation.The patient then used two the course of treatment medicament, the lower limb fiber crops send out symptom cool to eliminate fully, recover normally to reach recovery from illness.
Example 2, Jiang Na, woman, 48 years old.Flank pain, sciatica, the outer instep of thigh gaskin radiating pain.Play aggravation morning, stand up difficulty.Hospital is diagnosed as lumbar vertebra hyperosteogeny, and through taking Drug therapy of the present invention after two courses of treatment, pain relief can be free movable, and symptom is eliminated substantially; Fully recover after using for the 3rd course of treatment, activity and can do housework freely.
The specific embodiment
This kind Chinese medicine decoction that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration is characterized in that the crude drug of making effective ingredient by following weight is: Radix Dipsaci 10 grams, Radix Angelicae Pubescentis 10 grams, Radix Achyranthis Bidentatae 10 grams, Rhizoma Drynariae 30 grams, Caulis Spatholobi 45 grams, Herba Taxilli 12 grams, Semen Persicae 10 grams, Cortex Acanthopancis 15 grams.
Preparation and instructions of taking:
Be decocted in water for oral dose, every day, potion was obeyed 2~3 times for every dose, and 30 days is a course of treatment.

Claims (1)

1. a Chinese medicine decoction that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration is characterized in that, makes the raw materials of effective components medicine and by following weight is: Radix Dipsaci 10 grams, Radix Angelicae Pubescentis 10 grams, Radix Achyranthis Bidentatae 10 grams, Rhizoma Drynariae 30 grams, Caulis Spatholobi 45 grams, Herba Taxilli 12 grams, Semen Persicae 10 grams, Cortex Acanthopancis 15 grams.
CN2007101162003A 2007-12-19 2007-12-19 Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny Expired - Fee Related CN101185672B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007101162003A CN101185672B (en) 2007-12-19 2007-12-19 Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007101162003A CN101185672B (en) 2007-12-19 2007-12-19 Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny

Publications (2)

Publication Number Publication Date
CN101185672A true CN101185672A (en) 2008-05-28
CN101185672B CN101185672B (en) 2010-09-08

Family

ID=39478429

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007101162003A Expired - Fee Related CN101185672B (en) 2007-12-19 2007-12-19 Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny

Country Status (1)

Country Link
CN (1) CN101185672B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103599438A (en) * 2013-12-11 2014-02-26 张增仁 Traditional Chinese medicine tincture for treating bone diseases and preparation method thereof
CN104225487A (en) * 2014-09-28 2014-12-24 王星月 Traditional Chinese medicine for treating lumbar hyperosteogeny
CN104258285A (en) * 2014-09-28 2015-01-07 夏征梅 Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof
CN106215079A (en) * 2016-07-18 2016-12-14 王恩禄 A kind of Chinese medicine composition treating hyperosteogeny
CN106214766A (en) * 2016-08-29 2016-12-14 凯里市新元药店 A kind of Chinese medicine formula treating lumbar vertebra hyperosteogeny

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1186088C (en) * 2003-03-17 2005-01-26 爱新觉罗·恒绍 Tiegudan for ischemic necrosis of fernoral head
CN100579554C (en) * 2005-10-21 2010-01-13 任国安 Medicament for treating protrusion of intervertebral disc and preparation method thereof
CN100431577C (en) * 2006-01-12 2008-11-12 李保明 Medicine for treating femoral head necrosis and femur neck fracture and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103599438A (en) * 2013-12-11 2014-02-26 张增仁 Traditional Chinese medicine tincture for treating bone diseases and preparation method thereof
CN103599438B (en) * 2013-12-11 2016-03-09 张增仁 A kind of Traditional Chinese medicine tincture for the treatment of osteopathia and preparation method thereof
CN104225487A (en) * 2014-09-28 2014-12-24 王星月 Traditional Chinese medicine for treating lumbar hyperosteogeny
CN104258285A (en) * 2014-09-28 2015-01-07 夏征梅 Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof
CN106215079A (en) * 2016-07-18 2016-12-14 王恩禄 A kind of Chinese medicine composition treating hyperosteogeny
CN106214766A (en) * 2016-08-29 2016-12-14 凯里市新元药店 A kind of Chinese medicine formula treating lumbar vertebra hyperosteogeny

Also Published As

Publication number Publication date
CN101185672B (en) 2010-09-08

Similar Documents

Publication Publication Date Title
CN103263591B (en) External-use medicine for treating neck/lumbar disc herniation and osteoarthropathy
CN104189871A (en) Medicated wine for treating osteoproliferation
CN101185672B (en) Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny
CN105560662A (en) External-use traditional Chinese medicine composition for treating knee osteoarthritis
CN104857059A (en) Traditional Chinese medicine composition for curing cervical and lumbar vertebra diseases
CN101322786B (en) External-use medicament for treating bone fracture and traumatic injury
CN101199613B (en) Chinese medicine compound for treating lumbar hyperosteogeny
CN102342983B (en) Chinese medicinal composition for treating pain in the legs and numbness of the extremities and preparation method of preparation thereof
CN101317942B (en) Bone-setting alcohol
CN106362066A (en) Medicinal liquor for treatment of rheumatic and rheumatoid diseases and preparation method thereof
CN104258285A (en) Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof
CN104147512A (en) Traditional Chinese medicine composition for treating wet and cold type sciatica
CN103735809B (en) A kind of Chinese medicine decoction treating lumbar vertebra fracture
CN108030870A (en) It is a kind of to treat protrusion of lumber intervertebral disc and the plaster of bone fracture and preparation method thereof
CN102258647B (en) Externally-applied cherokee rose fruit/morinda officinalis/fenugreek powder for treating male impotence
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN100589819C (en) Chinese medicine for oral administration for treating lumbar hyperosteogeny
CN101204566B (en) Peroral Chinese traditional medicine composite for hyperosteogeny in knee joint
CN101204505B (en) Oral Chinese traditional medicine composition for osteoporosis
CN106421255A (en) Topical traditional Chinese composition and its application
CN104257965A (en) Traditional Chinese medicine for treating knee joint hyperostosis via oral and external administration and preparation method thereof
CN104352905A (en) Traditional Chinese medicine composition for treating closed fracture
CN105106521A (en) Analgesic for traumatic injuries
CN105560537A (en) Medicine composition for treating osteoartritis and preparation method thereof
CN106511828A (en) Chinese medicinal composition for treatment of acute lumbar sprain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100908

Termination date: 20101219